Wealthspire Advisors (Maryland)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,414
| Closed | -$1.16M | – | 493 |
|
|
2020
Q2 | $1.16M | Sell |
9,414
-654
| -6% | -$80.7K | 0.08% | 142 |
|
|
2020
Q1 | $851K | Buy |
10,068
+3,310
| +49% | +$280K | 0.07% | 157 |
|
|
2019
Q4 | $571K | Sell |
6,758
-2,040
| -23% | -$172K | 0.04% | 254 |
|
|
2019
Q3 | $593K | Buy |
8,798
+295
| +3% | +$19.9K | 0.04% | 229 |
|
|
2019
Q2 | $728K | Sell |
8,503
-9
| -0.1% | -$771 | 0.05% | 185 |
|
|
2019
Q1 | $756K | Sell |
8,512
-858
| -9% | -$76.2K | 0.06% | 176 |
|
|
2018
Q4 | $798K | Buy |
9,370
+718
| +8% | +$61.1K | 0.07% | 143 |
|
|
2018
Q3 | $839K | Buy |
8,652
+1,505
| +21% | +$146K | 0.07% | 166 |
|
|
2018
Q2 | $673K | Buy |
7,147
+1,164
| +19% | +$110K | 0.06% | 185 |
|
|
2018
Q1 | $485K | Buy |
5,983
+2,257
| +61% | +$183K | 0.05% | 252 |
|
|
2017
Q4 | $332K | Sell |
3,726
-1,111
| -23% | -$99K | 0.03% | 345 |
|
|
2017
Q3 | $450K | Buy |
4,837
+108
| +2% | +$10K | 0.05% | 257 |
|
|
2017
Q2 | $429K | Buy |
4,729
+512
| +12% | +$46.4K | 0.05% | 258 |
|
|
2017
Q1 | $370K | Buy |
4,217
+4,177
| +10,443% | +$366K | 0.05% | 245 |
|
|
2016
Q4 | $3K | Hold |
40
| – | – | ﹤0.01% | 1462 |
|
|
2016
Q3 | $4K | Hold |
40
| – | – | ﹤0.01% | 1419 |
|
|
2016
Q2 | $3K | Hold |
40
| – | – | ﹤0.01% | 1422 |
|
|
2016
Q1 | $3K | Buy |
40
+15
| +60% | +$1.13K | ﹤0.01% | 1435 |
|
|
2015
Q4 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 1445 |
|